Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Edan

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
La Revue Du Praticien|April 6, 1989
[Immunotherapy of multiple sclerosis]O Sabouraud, G Edan
Pathologie-Biologie|May 18, 2000
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?]G Edan, M Coustans
Revue Neurologique|May 4, 2020
Should spinal cord MRI be systematically performed for diagnosis and follow up of multiple sclerosis? YesA Kerbrat, G Edan
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1994
Experience with intravenous immunoglobulin in myasthenia gravis: a reviewG Edan, F Landgraf
La Revue Du Praticien|September 15, 1991
[Benign forms of multiple sclerosis]G Edan, O Sabouraud
Revue Neurologique|November 6, 2017
ForewordS Timsit, G Edan
Revue Neurologique|May 26, 2018
Induction or escalation therapy for patients with multiple sclerosis?E Le Page, G Edan
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
International MS Journal|January 19, 2006
Mitoxantrone in the treatment of multiple sclerosisS P Morrissey, E Le Page, G Edan
Revue Neurologique|January 1, 2016
Epidemiology of multiple sclerosisE Leray, T Moreau, A Fromont, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
La Revue Du Praticien|April 6, 1989
[Immunotherapy of multiple sclerosis]O Sabouraud, G Edan
Pathologie-Biologie|May 18, 2000
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?]G Edan, M Coustans
Revue Neurologique|May 4, 2020
Should spinal cord MRI be systematically performed for diagnosis and follow up of multiple sclerosis? YesA Kerbrat, G Edan
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1994
Experience with intravenous immunoglobulin in myasthenia gravis: a reviewG Edan, F Landgraf
La Revue Du Praticien|September 15, 1991
[Benign forms of multiple sclerosis]G Edan, O Sabouraud
Revue Neurologique|November 6, 2017
ForewordS Timsit, G Edan
Revue Neurologique|May 26, 2018
Induction or escalation therapy for patients with multiple sclerosis?E Le Page, G Edan
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
International MS Journal|January 19, 2006
Mitoxantrone in the treatment of multiple sclerosisS P Morrissey, E Le Page, G Edan
Revue Neurologique|January 1, 2016
Epidemiology of multiple sclerosisE Leray, T Moreau, A Fromont, et al.
Pageof 13